8/8/2026
SAMHSA gathers experts on psychedelics
AtaiBeckley and Compass Pathways explore new opportunities.
Topic archive
eli lilly
2 stories
7/17/2026
Eli Lilly acquires 5-MeO-DMT developer for $3.8B
Pharmaceutical giant expands into psychedelic research with major acquisition.